Literature DB >> 2227256

A case of idiopathic portal hypertension after renal transplantation.

N Yanagisawa1, H Sugaya, K Yunomura, T Harada, T Hisauchi.   

Abstract

A case of idiopathic portal hypertension (IPH) developing after renal transplantation is reported. A 33-year-old Japanese male who had undergone renal transplantation 8 years previously was transferred to our hospital because of hematemesis from ruptured esophageal varices. He had no history of any liver disease before the renal transplantation, but had a history of receiving blood transfusion. Abdominal computed tomography (CT) and ultrasonography revealed marked splenomegaly and collateral channels, but no obliteration which might cause portal hypertension in the hepatic or portal vein. No findings suggestive of hepatitis or liver cirrhosis were found either macroscopically on laparoscopy or by liver biopsy. Light microscopic study of the liver biopsy specimen showed mild periportal fibrosis, inconspicuous portal branches in the most peripheral tracts, but no pseudolobule formation or piecemeal necrosis. However collagen deposition was found in the perisinusoidal space and partly in intercellular space on electron microscopy. We consider that the development of portal hypertension in this case is responsible for the collagen deposition, which may be related to the administration of azathioprine after renal transplantation. There are few reports on IPH after renal transplantation, and it is stressed that a lower amount of azathioprine than previously reported may induce IPH under such conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227256     DOI: 10.1007/bf02779367

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  20 in total

1.  Spectrum of liver disease in renal transplant recipients.

Authors:  A J Ware; J P Luby; E H Eigenbrodt; D L Long; A R Hull
Journal:  Gastroenterology       Date:  1975-04       Impact factor: 22.682

2.  Ultrastructure of peliosis hepatis in a percutaneous biopsy.

Authors:  R C Ross; K Kovacs; E Horvath
Journal:  Pathol Eur       Date:  1972

3.  Hepatic dysfunction associated with renal transplantation.

Authors:  D B Evans; P R Millard; B M Herbertson
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

4.  Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment: a cause of chronic liver disease after kidney transplantation.

Authors:  P G Gerlag; J P van Hooff
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Idiopathic portal hypertension in a renal transplant recipient.

Authors:  J E Bredfeldt; R E Enriquez; R J Groszmann
Journal:  J Clin Gastroenterol       Date:  1982-04       Impact factor: 3.062

6.  Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy.

Authors:  H Weitz; J M Gokel; K Loeschke; K Possinger; M Eder
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  Peliosis hepatis in recipients of renal transplants.

Authors:  C Degott; B Rueff; H Kreis; A Duboust; F Potet; J P Benhamou
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

8.  Hepatic fibrosis in a child possibly due to prolonged methotrexate.

Authors:  A Talerman; R B Thompson
Journal:  J Clin Pathol       Date:  1966-01       Impact factor: 3.411

9.  Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation.

Authors:  P G Gerlag; S Lobatto; W M Driessen; P F Deckers; J P Van Hooff; E Schröder; K M Assmann; U J Van Haelst
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

10.  Portal hypertension in vinyl-chloride production workers.

Authors:  P M Smith; I R Crossley; D M Williams
Journal:  Lancet       Date:  1976-09-18       Impact factor: 79.321

View more
  1 in total

1.  "Endemic" idiopathic portal hypertension: report on 32 patients with non-cirrhotic portal fibrosis.

Authors:  C Vakili; M J Farahvash; T E Bynum
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.